Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058802) titled 'Searching for the genetic cause of Galloway-Mowat Syndrome' on Aug. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Kitasato University School of Medicine
Condition:
Condition - Galloway-Mowat Syndrome
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - To advance the elucidation of disease mechanisms by conducting genetic analyses, including whole-genome sequencing and RNA analyses in patients in Japan with confirmed and suspected Galloway-Mowat Syndrome.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients whom attending physician has diagnosed as having Galloway-Mowat syndrome or suspected Galloway-Mowat syndrome, in accordance with the following diagnostic criteria of Japan Intractable Disease Information Center.
Key exclusion criteria - Patients who did not provide informed consent to participate in the study.
Target Size - 20
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 06 Month 04 Day
Date of IRB - 2025 Year 06 Month 04 Day
Anticipated trial start date - 2025 Year 06 Month 04 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067234
Disclaimer: Curated by HT Syndication.
